Skip to content

Guided Self-help for Families With an Overweight Child

Guided Self-help Treatment for Families With an Overweight Child

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01145833
Acronym
GSH
Enrollment
50
Registered
2010-06-17
Start date
2009-10-31
Completion date
2011-10-31
Last updated
2020-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, guided self help treatment, treatment method, overweight, overweight children and parents, families with overweight child, efficacy, body mass index, weight

Brief summary

The purpose of this study is to evaluate whether a home based program can teach parents and moderately overweight kids who are of 8-12 years old with a BMI% between 85-97%, how to manage their child's weight. The study uses manuals and involves a short visit to the clinic every other week.

Detailed description

An estimated 4-5 million children between the ages of 6-17 in the United States are obese. Children who are obese are at an increased risk for many negative health consequences in childhood and in adulthood. In addition, these children are at an increased risk for psychosocial consequences in childhood and adolescence, including poor self-esteem, teasing, verbal abuse and social isolation. Guided self-help offers an opportunity to provide empirically based programs to a larger amount of the target population. Once such treatment methods are available, it is possible that the guided self-help treatment for childhood obesity can be disseminated to primary care practitioners, psychologists, nurses, and health educators. Ultimately, the goal of this application is to develop a treatment protocol that can be used by clinics and lay health professionals to intervene with children who are overweight and their parents.

Interventions

The immediate treatment group starts the 5-month treatment right after baseline assessment.

The delayed treatment group does not start treatment immediately after the baseline assessment. This group serves as the control group, by not receiving any treatment for 5 months. After the 5 months, the delayed group participants are asked to come in for a second assessment that involves completion of surveys and measurement of height, weight, and physical activity level. After this assessment is completed, the delayed group participants can begin the 5-month treatment.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* child between the ages of 8 & 12 * an moderately overweight child with a BMI% between 85-97% * child has a parent willing to participate * child has a parent who can read English at a minimum of a 6th grade level * family who is willing to commit to treatment attendance and attendance at all assessments.

Exclusion criteria

* Child psychiatric disorder diagnoses (based on parent report) * Child diagnoses of a serious current physical disease (such as diabetes) * Child who is taking medications that may impact their weight * Child with physical difficulties that limit the ability to exercise * Child with an active eating disorder * Child and parent will be moving out of the San Diego County before study completion * Child and/or parent has a modified diet due to religious or socially conscious reasons (such as Vegan, vegetarian)

Design outcomes

Primary

MeasureTime frame
Child BMI5 months

Secondary

MeasureTime frame
Parent BMI5 months

Countries

United States

Participant flow

Participants by arm

ArmCount
Immediate Treatment Group
The immediate treatment group begins the 5-month treatment immediately after baseline assessment.
25
Delayed Treatment Group
The delayed treatment group serves as the control group.
25
Total50

Baseline characteristics

CharacteristicImmediate Treatment GroupDelayed Treatment GroupTotal
Age, Continuous10.3 years
STANDARD_DEVIATION 1.3
10.5 years
STANDARD_DEVIATION 1.4
10.4 years
STANDARD_DEVIATION 1.35
Child BMI24.1 kg/m^2
STANDARD_DEVIATION 1.9
24.4 kg/m^2
STANDARD_DEVIATION 2.6
24.2 kg/m^2
STANDARD_DEVIATION 2.3
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants4 Participants7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
22 Participants21 Participants43 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Parent BMI27.5 kg/m^2
STANDARD_DEVIATION 6.1
27.9 kg/m^2
STANDARD_DEVIATION 6.1
27.7 kg/m^2
STANDARD_DEVIATION 6.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Black or African American
2 Participants1 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
21 Participants21 Participants42 Participants
Region of Enrollment
United States
25 participants25 participants50 participants
Sex: Female, Male
Female
15 Participants16 Participants31 Participants
Sex: Female, Male
Male
10 Participants9 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
0 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Child BMI

Time frame: 5 months

ArmMeasureValue (MEAN)Dispersion
Immediate Treatment GroupChild BMI23.3 kg/m^2Standard Deviation 2.1
Delayed Treatment GroupChild BMI25.17 kg/m^2Standard Deviation 2.79
Secondary

Parent BMI

Time frame: 5 months

ArmMeasureValue (MEAN)Dispersion
Immediate Treatment GroupParent BMI26.8 kg/m^2Standard Deviation 6.4
Delayed Treatment GroupParent BMI28.0 kg/m^2Standard Deviation 6.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026